Harel Insurance Investments & Financial Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.11M | Sell |
5,682
-25,894
| -82% | -$5.37M | 0.01% | 189 |
|
|
2026
Q1 | $7.09M | Buy |
31,576
+9,937
| +46% | +$2.48M | 0.05% | 92 |
|
|
2025
Q4 | $5.21M | Sell |
21,639
-7,916
| -27% | -$2.02M | 0.05% | 114 |
|
|
2025
Q3 | $8.08M | Sell |
29,555
-3,922
| -12% | -$1.07M | 0.07% | 92 |
|
|
2025
Q2 | $8.64M | Buy |
33,477
+1,925
| +6% | +$459K | 0.1% | 89 |
|
|
2025
Q1 | $7.06M | Buy |
31,552
+31,348
| +15,367% | +$7.32M | 0.09% | 97 |
|
|
2024
Q4 | $47K | Sell |
204
-13,480
| -99% | -$3.25M | ﹤0.01% | 313 |
|
|
2024
Q3 | $3.34M | Sell |
13,684
-11,347
| -45% | -$2.54M | 0.06% | 101 |
|
|
2024
Q2 | $4.79M | Buy |
25,031
+10,053
| +67% | +$2.04M | 0.09% | 78 |
|
|
2024
Q1 | $2.97M | Buy |
14,978
+14,539
| +3,312% | +$2.66M | 0.06% | 102 |
|
|
2023
Q4 | $76K | Sell |
439
-20
| -4% | -$3.07K | ﹤0.01% | 380 |
|
|
2023
Q3 | $68K | Buy |
459
+100
| +28% | +$18.1K | ﹤0.01% | 421 |
|
|
2023
Q2 | $78K | Sell |
359
-2
| -0.6% | -$446 | ﹤0.01% | 420 |
|
|
2023
Q1 | $79K | Buy |
361
+13
| +4% | +$2.82K | ﹤0.01% | 436 |
|
|
2022
Q4 | $72K | Sell |
348
-103
| -23% | -$22.6K | ﹤0.01% | 422 |
|
|
2022
Q3 | $99K | Sell |
451
-92
| -17% | -$20.9K | ﹤0.01% | 385 |
|
|
2022
Q2 | $114K | Sell |
543
-89
| -14% | -$18.9K | ﹤0.01% | 389 |
|
|
2022
Q1 | $153K | Sell |
632
-522
| -45% | -$126K | ﹤0.01% | 386 |
|
|
2021
Q4 | $302K | Sell |
1,154
-1,538
| -57% | -$399K | 0.01% | 321 |
|
|
2021
Q3 | $709K | Sell |
2,692
-3,062
| -53% | -$837K | 0.02% | 193 |
|
|
2021
Q2 | $1.9M | Sell |
5,754
-9,431
| -62% | -$1.98M | 0.04% | 203 |
|
|
2021
Q1 | $6.73M | Buy |
15,185
+13,482
| +792% | +$2.7M | 0.13% | 96 |
|
|
2020
Q4 | $1.12M | Buy |
1,703
+90
| +6% | +$17.9K | 0.03% | 269 |
|
|
2020
Q3 | $277K | Buy |
+1,613
| New | +$298K | 0.01% | 256 |
|
|
2020
Q2 | – | Sell |
-86
| Closed | -$13K | – | 573 |
|
|
2020
Q1 | $13K | Hold |
86
| – | – | ﹤0.01% | 381 |
|
|
2019
Q4 | $13K | Hold |
86
| – | – | ﹤0.01% | 428 |
|
|
2019
Q3 | $11K | Hold |
86
| – | – | ﹤0.01% | 440 |
|
|
2019
Q2 | $10K | Hold |
86
| – | – | ﹤0.01% | 427 |
|
|
2019
Q1 | $9K | Sell |
86
-171
| -67% | -$17.6K | ﹤0.01% | 407 |
|
|
2018
Q4 | $29K | Hold |
257
| – | – | ﹤0.01% | 341 |
|
|
2018
Q3 | $30K | Hold |
257
| – | – | ﹤0.01% | 397 |
|
|
2018
Q2 | $27K | Hold |
257
| – | – | ﹤0.01% | 369 |
|
|
2018
Q1 | $25K | Hold |
257
| – | – | ﹤0.01% | 375 |
|
|
2017
Q4 | $22K | Buy |
257
+119
| +86% | +$9.83K | ﹤0.01% | 398 |
|
|
2017
Q3 | $11K | Hold |
138
| – | – | ﹤0.01% | 393 |
|
|
2017
Q2 | $11K | Hold |
138
| – | – | ﹤0.01% | 391 |
|
|
2017
Q1 | $10K | Hold |
138
| – | – | ﹤0.01% | 391 |
|
|
2016
Q4 | $9K | Hold |
138
| – | – | ﹤0.01% | 308 |
|
|
2016
Q3 | $9K | Hold |
138
| – | – | ﹤0.01% | 393 |
|
|
2016
Q2 | $9K | Hold |
138
| – | – | ﹤0.01% | 569 |
|
|
2016
Q1 | $8K | Buy |
+138
| New | +$7.81K | ﹤0.01% | 377 |
|
Other funds holding RMD
Harel Insurance Investments & Financial Services's RMD Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services reduced its ResMed (RMD) stake by 82% in Q2 2026, selling an estimated $5.37M and leaving 5,682 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #189.
Harel Insurance Investments & Financial Services first reported a position in RMD in Q1 2016 and has held it in 41 quarters since. The position peaked at $8.64M in Q2 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Harel Insurance Investments & Financial Services held 5,682 shares of ResMed worth $1.11M as of Q2 2026.
- Harel Insurance Investments & Financial Services sold 25,894 ResMed shares in Q2 2026, an estimated $5.37M.
- ResMed made up 0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #189 holding.
- Harel Insurance Investments & Financial Services first reported a position in ResMed in Q1 2016 and has held it in 41 quarters since.
- Harel Insurance Investments & Financial Services's ResMed position peaked at $8.64M in Q2 2025.
- 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.